|Day Low/High||0.67 / 0.72|
|52 Wk Low/High||0.49 / 1.40|
Trade-Ideas LLC identified OxiGene (OXGN) as a "perilous reversal" (up big yesterday but down big today) candidate
Trade-Ideas LLC identified OxiGene (OXGN) as a pre-market mover with heavy volume candidate
A combination of Oxigene's Zybrestat and Roche's Avastin delayed the regrowth of tumors in women with advanced ovarian cancer.
Trial Achieves Primary Efficacy Endpoint of a Statistically Significant Increase in Progression-Free Survival
Trial Achieves Primary Efficacy Endpoint of a Statistically Significant Reduction in Progression-Free Survival
These under-$10 stocks look ready to trade higher from current levels.
Poster Presentation on December 7, 2013 at the ASH Conference in New Orleans
Poster Presentation Slated for October 20, 2013 at AACR-NCI-EORTC Conference in Boston
These stocks are within range of triggering breakout trades.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of OXiGENE, Inc.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.